Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Baoying Huang and Wenling Wang.
Baoying Huang
Connection Strength
0.955
Wenling Wang
  1. Profiles of SARS-CoV-2 RNA and Antibodies in Inpatients with COVID-19 not Related with Clinical Manifestation: A Single Centre Study. Virol Sin. 2021 10; 36(5):1088-1092.
    View in: PubMed
    Score: 0.060
  2. A core-shell structured COVID-19 mRNA vaccine with favorable biodistribution pattern and promising immunity. Signal Transduct Target Ther. 2021 05 31; 6(1):213.
    View in: PubMed
    Score: 0.059
  3. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial. Lancet Infect Dis. 2021 01; 21(1):39-51.
    View in: PubMed
    Score: 0.057
  4. Development and effectiveness of pseudotyped SARS-CoV-2 system as determined by neutralizing efficiency and entry inhibition test in vitro. Biosaf Health. 2020 Dec; 2(4):226-231.
    View in: PubMed
    Score: 0.056
  5. Morphogenesis and cytopathic effect of SARS-CoV-2 infection in human airway epithelial cells. Nat Commun. 2020 08 06; 11(1):3910.
    View in: PubMed
    Score: 0.056
  6. Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections. EBioMedicine. 2020 Aug; 58:102890.
    View in: PubMed
    Score: 0.056
  7. Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2. Cell. 2020 08 06; 182(3):713-721.e9.
    View in: PubMed
    Score: 0.055
  8. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice. Nature. 2020 07; 583(7818):830-833.
    View in: PubMed
    Score: 0.055
  9. Age-related rhesus macaque models of COVID-19. Animal Model Exp Med. 2020 Mar; 3(1):93-97.
    View in: PubMed
    Score: 0.055
  10. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020 02 22; 395(10224):565-574.
    View in: PubMed
    Score: 0.054
  11. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020 02 20; 382(8):727-733.
    View in: PubMed
    Score: 0.054
  12. High-Throughput Screening and Identification of Potent Broad-Spectrum Inhibitors of Coronaviruses. J Virol. 2019 06 15; 93(12).
    View in: PubMed
    Score: 0.052
  13. Humoral and cellular immunity against both ZIKV and poxvirus is elicited by a two-dose regimen using DNA and non-replicating vaccinia virus-based vaccine candidates. Vaccine. 2019 04 03; 37(15):2122-2130.
    View in: PubMed
    Score: 0.051
  14. Significant Spike-Specific IgG and Neutralizing Antibodies in Mice Induced by a Novel Chimeric Virus-Like Particle Vaccine Candidate for Middle East Respiratory Syndrome Coronavirus. Virol Sin. 2018 Oct; 33(5):453-455.
    View in: PubMed
    Score: 0.050
  15. Ultrapotent Human Neutralizing Antibody Repertoires Against Middle East Respiratory Syndrome Coronavirus From a Recovered Patient. J Infect Dis. 2018 09 08; 218(8):1249-1260.
    View in: PubMed
    Score: 0.049
  16. Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus. Emerg Microbes Infect. 2018 Apr 04; 7(1):60.
    View in: PubMed
    Score: 0.048
  17. A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein. Emerg Microbes Infect. 2017 Jun 28; 6(6):e60.
    View in: PubMed
    Score: 0.045
  18. A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein. Emerg Microbes Infect. 2017 May 24; 6(5):e37.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.